These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 12019149)

  • 41. Efficient inhibition of ovarian cancer growth and prolonged survival by transfection with a novel pro-apoptotic gene, hPNAS-4, in a mouse model. In vivo and in vitro results.
    Yang F; Li Z; Deng H; Yang H; Yan F; Qian Z; Chen L; Wei Y; Zhao X
    Oncology; 2008; 75(3-4):137-44. PubMed ID: 18824876
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Different clinical roles for p21-activated kinase-1 in primary and recurrent ovarian carcinoma.
    Davidson B; Shih IeM; Wang TL
    Hum Pathol; 2008 Nov; 39(11):1630-6. PubMed ID: 18656238
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Increased expression of dipeptidyl peptidase IV in human mesothelial cells by malignant ascites from ovarian carcinoma patients.
    Kajiyama H; Kikkawa F; Maeda O; Suzuki T; Ino K; Mizutani S
    Oncology; 2002; 63(2):158-65. PubMed ID: 12239451
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dipeptidyl peptidase IV (DPPIV) inhibits cellular invasion of melanoma cells.
    Pethiyagoda CL; Welch DR; Fleming TP
    Clin Exp Metastasis; 2000; 18(5):391-400. PubMed ID: 11467771
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Oxytocin inhibits the progression of human ovarian carcinoma cells in vitro and in vivo.
    Morita T; Shibata K; Kikkawa F; Kajiyama H; Ino K; Mizutani S
    Int J Cancer; 2004 Apr; 109(4):525-32. PubMed ID: 14991573
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Differential Expression and Enzymatic Activity of DPPIV/CD26 Affects Migration Ability of Cervical Carcinoma Cells.
    Beckenkamp A; Willig JB; Santana DB; Nascimento J; Paccez JD; Zerbini LF; Bruno AN; Pilger DA; Wink MR; Buffon A
    PLoS One; 2015; 10(7):e0134305. PubMed ID: 26222679
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dipeptidyl peptidase IV in cell proliferation and differentiation.
    Sedo A; Kraml J
    Sb Lek; 1994; 95(4):285-88. PubMed ID: 8867699
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Survival time and invasive activity due to dipeptidyl peptidase IV overexpression in ovarian carcinoma.
    Mizutani S; Kajiyama H; Suzuki T; Shibata K; Ino K; Kikkawa F
    Adv Exp Med Biol; 2003; 524():253-6. PubMed ID: 12675247
    [No Abstract]   [Full Text] [Related]  

  • 49. Expression levels of seprase/FAPα and DPPIV/CD26 in epithelial ovarian carcinoma.
    Zhang M; Xu L; Wang X; Sun B; Ding J
    Oncol Lett; 2015 Jul; 10(1):34-42. PubMed ID: 26170973
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The expression of dipeptidyl peptidase IV (DPPIV/CD26) is associated with enhanced chemosensitivity to paclitaxel in epithelial ovarian carcinoma cells.
    Kajiyama H; Shibata K; Ino K; Mizutani S; Nawa A; Kikkawa F
    Cancer Sci; 2010 Feb; 101(2):347-54. PubMed ID: 19917055
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A Systems Biology Approach Unveils a Critical Role of DPP4 in Upper Gastrointestinal Cancer Patient Outcomes.
    Kotnala S; Dhasmana A; Dhasmana S; Haque S; Yallapu MM; Tripathi MK; Jaggi M; Chauhan SC
    J Environ Pathol Toxicol Oncol; 2024; 43(2):43-55. PubMed ID: 38505912
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inhibition of Dipeptidyl Peptidase-4 Activates Autophagy to Promote Survival of Breast Cancer Cells via the mTOR/HIF-1α Pathway.
    Kawakita E; Yang F; Shi S; Takagaki Y; Koya D; Kanasaki K
    Cancers (Basel); 2023 Sep; 15(18):. PubMed ID: 37760498
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Transcriptomic and Functional Evidence for Differential Effects of MCF-7 Breast Cancer Cell-Secretome on Vascular and Lymphatic Endothelial Cell Growth.
    Azzarito G; Visentin M; Leeners B; Dubey RK
    Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806196
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Roles of Dipeptidyl Peptidase 4 (DPP4) and DPP4 Inhibitors in Different Lung Diseases: New Evidence.
    Zhang T; Tong X; Zhang S; Wang D; Wang L; Wang Q; Fan H
    Front Pharmacol; 2021; 12():731453. PubMed ID: 34955820
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CD26/DPP-4: Type 2 Diabetes Drug Target with Potential Influence on Cancer Biology.
    Kawakita E; Koya D; Kanasaki K
    Cancers (Basel); 2021 May; 13(9):. PubMed ID: 34063285
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cancer Biology and Prevention in Diabetes.
    Srivastava SP; Goodwin JE
    Cells; 2020 Jun; 9(6):. PubMed ID: 32498358
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Expression of connective tissue growth factor as a prognostic indicator and its possible involvement in the aggressive properties of epithelial ovarian carcinoma.
    Shimbo A; Kajiyama H; Tamauchi S; Yoshikawa N; Ikeda Y; Nishino K; Suzuki S; Niimi K; Sakata J; Kikkawa F
    Oncol Rep; 2019 Dec; 42(6):2323-2332. PubMed ID: 31578579
    [TBL] [Abstract][Full Text] [Related]  

  • 58. LncRNA-OIS1 regulates DPP4 activation to modulate senescence induced by RAS.
    Li L; van Breugel PC; Loayza-Puch F; Ugalde AP; Korkmaz G; Messika-Gold N; Han R; Lopes R; Barbera EP; Teunissen H; de Wit E; Soares RJ; Nielsen BS; Holmstrøm K; Martínez-Herrera DJ; Huarte M; Louloupi A; Drost J; Elkon R; Agami R
    Nucleic Acids Res; 2018 May; 46(8):4213-4227. PubMed ID: 29481642
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibition of ZEB1 leads to inversion of metastatic characteristics and restoration of paclitaxel sensitivity of chronic chemoresistant ovarian carcinoma cells.
    Sakata J; Utsumi F; Suzuki S; Niimi K; Yamamoto E; Shibata K; Senga T; Kikkawa F; Kajiyama H
    Oncotarget; 2017 Nov; 8(59):99482-99494. PubMed ID: 29245917
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Involvement of DPP9 in gene fusions in serous ovarian carcinoma.
    Smebye ML; Agostini A; Johannessen B; Thorsen J; Davidson B; Tropé CG; Heim S; Skotheim RI; Micci F
    BMC Cancer; 2017 Sep; 17(1):642. PubMed ID: 28893231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.